Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Hair greying is linked to reduced ATM protein in hair cells, which protects against stress and damage.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

HIV patients with lower CD4 T cell counts often have more skin problems.

Dermoscopy helps diagnose syphilitic alopecia, and treatment with penicillin can regrow hair.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

A genetic duplication on chromosome 5 was linked to a woman's unique combination of medical conditions.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

ceRNA networks offer potential treatments for skin aging and wound healing.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

AIDS may cause changes in the scalp that increase infection risk and hair loss.